Target Price | €346.79 |
Price | €357.00 |
Deviation | 2.86% |
Number of Estimates | 19 |
19 Analysts have issued a price target Allianz 2026 . The average Allianz target price is €346.79. This is 2.86% lower than the current stock price. The highest price target is €407.00 14.01% , the lowest is €295.00 17.37% . | |
A rating was issued by 21 analysts: 12 Analysts recommend Allianz to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Allianz stock has an average upside potential 2026 of 2.86% . Most analysts recommend the Allianz stock at Purchase. |
6 Analysts have issued a sales forecast Allianz 2025 . The average Allianz sales estimate is €179b . This is 15.52% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €190b 22.95% , the lowest is €168b 8.58% .
This results in the following potential growth metrics:
2024 | €137b | 9.93% |
---|---|---|
2025 | €179b | 30.54% |
2026 | €188b | 5.17% |
2027 | €176b | 6.37% |
2028 | €193b | 9.61% |
2029 | €201b | 4.16% |
16 Allianz Analysts have issued a net profit forecast 2025. The average Allianz net profit estimate is €10.6b . This is 8.97% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €11.1b 13.53% , the lowest is €10.1b 3.87% .
This results in the following potential growth metrics and future Net Margins:
2024 | €9.7b | 16.88% |
---|---|---|
2025 | €10.6b | 9.49% |
2026 | €11.5b | 8.44% |
2027 | €12.4b | 7.43% |
2028 | €12.9b | 3.88% |
2029 | €13.8b | 6.97% |
2024 | 7.10% | 6.33% |
---|---|---|
2025 | 5.95% | 16.18% |
2026 | 6.14% | 3.19% |
2027 | 7.04% | 14.66% |
2028 | 6.68% | 5.11% |
2029 | 6.86% | 2.69% |
16 Analysts have issued a Allianz forecast for earnings per share. The average Allianz EPS is €27.59 . This is 8.97% higher than earnings per share in the financial year 2024. The highest EPS forecast is €28.75 13.55% , the lowest is €26.30 3.87% .
This results in the following potential growth metrics and future valuations:
2024 | €25.20 | 16.88% |
---|---|---|
2025 | €27.59 | 9.48% |
2026 | €29.92 | 8.45% |
2027 | €32.15 | 7.45% |
2028 | €33.39 | 3.86% |
2029 | €35.72 | 6.98% |
Current | 14.10 | 9.05% |
---|---|---|
2025 | 12.94 | 8.23% |
2026 | 11.93 | 7.81% |
2027 | 11.11 | 6.87% |
2028 | 10.69 | 3.78% |
2029 | 9.99 | 6.55% |
Based on analysts' sales estimates for 2025, the Allianz stock is valued at an EV/Sales of 0.78 and an P/S ratio of 0.77 .
This results in the following potential growth metrics and future valuations:
Current | 0.91 | 8.33% |
---|---|---|
2025 | 0.78 | 13.85% |
2026 | 0.75 | 4.91% |
2027 | 0.80 | 6.80% |
2028 | 0.73 | 8.77% |
2029 | 0.70 | 3.99% |
Current | 0.89 | 1.66% |
---|---|---|
2025 | 0.77 | 13.44% |
2026 | 0.73 | 4.91% |
2027 | 0.78 | 6.80% |
2028 | 0.71 | 8.77% |
2029 | 0.69 | 3.98% |
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Jan 03 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Dec 12 2024 |
INTESA SANPAOLO EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Dec 10 2024 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Dec 10 2024 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Dec 09 2024 |
BNP PARIBAS EXANE |
Underperform
➜
Underperform
|
Unchanged | Dec 04 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
Analyst Rating | Date |
---|---|
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Jan 03 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Dec 12 2024 |
Unchanged
INTESA SANPAOLO EQUITY RESEARCH:
Buy
➜
Buy
|
Dec 10 2024 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Dec 10 2024 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Dec 09 2024 |
Unchanged
BNP PARIBAS EXANE:
Underperform
➜
Underperform
|
Dec 04 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.